Gilpin Wealth Management’s GSK GSK Stock Holding History

Gilpin Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.26K	Hold	59	–	–	﹤0.01%	386
2025 Q4	$2.89K	Buy	+59	New	+$2.75K	﹤0.01%	374

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Gilpin Wealth Management's GSK Position: Q1 2026 in Review

Gilpin Wealth Management held its GSK (GSK) position steady in Q1 2026 at 59 shares worth $3.26K. The position accounts for ﹤0.01% of the portfolio, ranked #386.

Gilpin Wealth Management first reported a position in GSK in Q4 2025 and has held it in 2 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Gilpin Wealth Management held 59 shares of GSK worth $3.26K as of Q1 2026.
Gilpin Wealth Management left its GSK share count unchanged in Q1 2026.
GSK made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q1 2026, its #386 holding.
Gilpin Wealth Management first reported a position in GSK in Q4 2025 and has held it in 2 quarters since.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Gilpin Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.